10-Q 1 covs-20150630x10q.htm COVS Q1 FY 16 10-Q COVS-2015.06.30-10Q
As filed with the Securities and Exchange Commission on August 7, 2015
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2015
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-36088
 
Covisint Corporation
(Exact name of registrant as specified in its charter)
MICHIGAN
(State or other jurisdiction of
incorporation or organization)
 
 
 
26-2318591
(I.R.S. Employer
Identification Number)
 
 
26533 Evergreen Road, Suite 500, Southfield, Michigan 48076
(248) 483-2000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.          Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).             Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o
 
 
  
Accelerated filer  o
Non-accelerated filer    x
 
(Do not check if a smaller reporting company)
  
Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
Indicate the number of shares outstanding of each of the issuer's class of common stock, as of the latest practicable date:
As of August 5, 2015, there were outstanding 39,274,809 shares of Common Stock, no par value, of the registrant.





 
 
 
Item 3. Default Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
SIGNATURES

Cautionary Statement
This Quarterly Report on Form 10-Q (“Quarterly Report”) and the documents incorporated herein by reference contain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), based on expectations, estimates, and projections as of the date of this filing. Actual results may differ materially from those expressed in forward-looking statements. See Item 1A-“Risk Factors” in this Quarterly Report.






COVISINT CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands)
(Unaudited)
 
June 30, 2015
 
March 31, 2015
ASSETS
 
 
 
CURRENT ASSETS:
 
 
 
Cash

$47,187

 

$50,077

Accounts receivable, net
12,811

 
15,348

Deferred tax asset, net

 
16

Prepaid expenses
3,162

 
3,160

Other current assets
2,975

 
4,209

Total current assets
66,135

 
72,810

PROPERTY AND EQUIPMENT, LESS ACCUMULATED DEPRECIATION AND AMORTIZATION
9,918

 
8,809

CAPITALIZED SOFTWARE AND OTHER INTANGIBLE ASSETS, NET
10,143

 
10,646

OTHER:
 
 
 
Goodwill
25,385

 
25,385

Deferred costs
1,256

 
1,736

Deferred tax asset, net
1,657

 
1,528

Other assets
641

 
928

Total other assets
28,939

 
29,577

TOTAL ASSETS

$115,135

 

$121,842

LIABILITIES AND SHAREHOLDERS' EQUITY
 
 
 
CURRENT LIABILITIES:
 
 
 
Accounts payable

$5,325

 

$7,703

Accrued commissions
1,134

 
3,286

Deferred revenue
21,297

 
18,029

Accrued expenses
3,209

 
3,344

Deferred tax liability, net
1,777

 
1,597

Total current liabilities
32,742

 
33,959

DEFERRED REVENUE
3,099

 
3,914

ACCRUED LIABILITIES
3,138

 
2,622

Total liabilities
38,979

 
40,495

COMMITMENTS AND CONTINGENCIES


 


SHAREHOLDERS' EQUITY:
 
 
 
Preferred stock, no par value - authorized 5,000,000 shares; none issued and outstanding

 

Common stock, no par value - authorized 50,000,000 shares; issued and outstanding 39,170,215 (39,033,900 issued and outstanding as of March 31, 2015)

 

Additional paid-in capital
158,396

 
157,004

Retained deficit
(82,219
)
 
(75,633
)
Accumulated other comprehensive loss
(21
)
 
(24
)
Total shareholders' equity
76,156

 
81,347

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

$115,135

 

$121,842


See notes to condensed consolidated financial statements.

2


COVISINT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In Thousands, Except Per Share Data)
(Unaudited)
 
 
Three Months Ended 
 June 30,
 
2015
 
2014
REVENUE

$18,482

 

$21,587

COST OF REVENUE
9,777

 
15,266

GROSS PROFIT
8,705

 
6,321

OPERATING EXPENSES:
 
 
 
Research and development
3,663

 
3,116

Sales and marketing
7,476

 
9,772

General and administrative
4,087

 
5,546

Total operating expenses
15,226

 
18,434

OPERATING LOSS
(6,521
)
 
(12,113
)
Other income
2

 
22

LOSS BEFORE INCOME TAX PROVISION
(6,519
)
 
(12,091
)
INCOME TAX PROVISION
67

 
25

NET LOSS

($6,586
)
 

($12,116
)
Basic and diluted loss per share

($0.17
)
 

($0.32
)
OTHER COMPREHENSIVE INCOME, NET OF TAX
 
 
 
Foreign currency translation adjustments
3

 
7

OTHER COMPREHENSIVE INCOME, NET OF TAX
3

 
7

COMPREHENSIVE LOSS

($6,583
)
 

($12,109
)

See notes to condensed consolidated financial statements.



3


COVISINT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
THREE MONTHS ENDED JUNE 30, 2015
(In Thousands, Except Share Data)
(Unaudited)

 
 
Common Stock
 
Additional
Paid-In Capital
 
Retained Deficit
 
Accumulated
Other
Comprehensive Loss
 
Total
Shareholder’s Equity
 
Shares
 
Amount
 
 
 
BALANCE AT MARCH 31, 2015
39,033,900

 

$—

 

$157,004

 

($75,633
)
 

($24
)
 

$81,347

Net loss
 
 
 
 
 
 
(6,586
)
 
 
 
(6,586
)
Covisint stock compensation (Note 5)
 
 
 
 
1,149

 
 
 
 
 
1,149

Covisint stock option exercise
136,315

 
 
 
247

 
 
 
 
 
247

Income taxes
 
 
 
 
(4
)
 
 
 
 
 
(4
)
Foreign currency translation
 
 
 
 
 
 
 
 
3

 
3

BALANCE AT JUNE 30, 2015
39,170,215

 

$—

 

$158,396

 

($82,219
)
 

($21
)
 

$76,156


See notes to condensed consolidated financial statements.


4


COVISINT CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands)
(Unaudited)
 
 
Three Months Ended 
 June 30,
 
2015
 
2014
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
 
 
 
Net loss

($6,586
)
 

($12,116
)
Adjustments to reconcile net loss to cash provided by (used in) operations:
 
 
 
Depreciation and amortization
1,738

 
2,343

Deferred income taxes
67

 
(53
)
Stock award compensation
1,149

 
2,619

Other
32

 

Net change in assets and liabilities:
 
 
 
Accounts receivable
2,542

 
3,108

Other assets
2,004

 
458

Accounts payable and accrued expenses (1)
(3,280
)
 
(438
)
Deferred revenue
2,429

 
(3,898
)
Net cash provided by (used in) operating activities
95

 
(7,977
)
CASH FLOWS USED IN INVESTING ACTIVITIES:
 
 
 
Purchase of:
 
 
 
Property and equipment (1)
(2,874
)
 
(820
)
Capitalized software
(401
)
 
(790
)
Net cash used in investing activities
(3,275
)
 
(1,610
)
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:
 
 
 
Cash payments from former parent company

 
8,775

Cash payments to former parent company

 
(5,787
)
Net proceeds from exercise of stock awards
247

 
196

Net cash provided by financing activities
247

 
3,184

EFFECT OF EXCHANGE RATE CHANGES ON CASH
43

 
(4
)
NET CHANGE IN CASH
(2,890
)
 
(6,407
)
CASH AT BEGINNING OF PERIOD
50,077

 
49,536

CASH AT END OF PERIOD

$47,187

 

$43,129


(1)
Accounts payable and accrued expenses in the balance sheet as of June 30, 2015 include $0.5 million associated with purchases of property and equipment, which are non-cash acquisitions of fixed assets as of June 30, 2015.

See notes to condensed consolidated financial statements.

5


COVISINT CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The accompanying unaudited condensed consolidated financial statements (“Financial Statements”) include the accounts of Covisint Corporation, a Michigan corporation, and subsidiaries ("Covisint", "the Company", "we", "our", and "us").

On October 31, 2014, Covisint ceased being a subsidiary of Compuware Corporation (“Compuware”) as a result of Compuware's distribution of its holdings of Covisint common stock to Compuware shareholders ("the October 2014 Distribution"). Prior to October 31, 2014, Covisint was majority-owned by Compuware.

The Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), for interim financial information and with the instructions of Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, contingencies and results of operations. While management has based its assumptions and estimates on the facts and circumstances existing at June 30, 2015, final amounts may differ from these estimates. In the opinion of the Company’s management, the accompanying Financial Statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented.

The Company has evaluated subsequent events through the date these financial statements were issued.

These financial statements should be read in conjunction with the Company's 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s accounting policies as disclosed in the Company’s 2015 Annual Report on Form 10-K.

Recently Issued Accounting Pronouncements
         
In May 2014, the FASB issued ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," a new comprehensive revenue recognition standard that will supersede all existing revenue recognition guidance under U.S. GAAP. The standard's core principle is that revenue should be recognized as goods or services are transferred to a customer in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the delay, this ASU will now be effective for annual and interim periods beginning on or after December 15, 2017, with early adoption permitted. Entities will have the option of using either a full retrospective approach or a modified approach to adopt the guidance in the ASU. The Company is currently evaluating the impact of adopting this guidance.

    
2.    CAPITALIZED SOFTWARE AND OTHER INTANGIBLE ASSETS
The components of the Company’s intangible assets are as follows (in thousands):
 

6


 
June 30, 2015
 
Gross  Carrying
Amount

Accumulated
Amortization

Net Carrying
Amount
Indefinite-lived intangible assets:





Trademarks(1)

$358

 
 
 

$358

Amortizing intangible assets:
 
 
 
 
 
Capitalized software(2)

$34,741

 

($24,956
)
 

$9,785

Customer relationship agreements
2,585

 
(2,585
)
 

Trademarks
80

 
(80
)
 

Total amortizing intangible assets

$37,406

 

($27,621
)
 

$9,785

 
 
March 31, 2015
 
Gross  Carrying
Amount
 
Accumulated
Amortization
 
Net Carrying
Amount
Indefinite-lived intangible assets:
 
 
 
 
 
Trademarks(1)

$358

 
 
 

$358

Amortizing intangible assets:
 
 
 
 
 
Capitalized software(2)

$34,340

 

($24,052
)
 

$10,288

Customer relationship agreements
2,585

 
(2,585
)
 

Trademarks
80

 
(80
)
 

Total amortizing intangible assets

$37,005

 

($26,717
)
 

$10,288

_____________________________________________________
(1)
The Covisint trademarks were acquired by Compuware in an acquisition in March 2004 and contributed to Covisint by Compuware effective January 1, 2013. These trademarks are deemed to have an indefinite life and therefore are not being amortized.
(2)
Amortization of capitalized software is included in “cost of revenue” in the condensed consolidated statements of comprehensive loss. Capitalized software is generally amortized over five years.


Amortization expense of intangible assets was $0.9 million and $1.8 million for the three months ended June 30, 2015 and 2014. Estimated future amortization expense, based on identified intangible assets at June 30, 2015, is expected to be as follows (in thousands):

 
 
At June 30, 2015 for the Year Ending March 31,
 
2016
 
2017
 
2018
 
2019
 
2020
Capitalized software

$2,496

 

$3,084

 

$2,396

 

$1,046

 

$677


3.    EARNINGS PER COMMON SHARE

Basic earnings per common share (“EPS”) is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted EPS assumes the issuance of common stock for all potentially dilutive equivalent shares outstanding using the treasury method.

EPS data were computed as follows (in thousands, except for per share data):

7


 
Three Months Ended June 30,
 
2015
 
2014
Basic loss per share:
 
 
 
Numerator: Net loss

($6,586
)
 

($12,116
)
Denominator:
 
 
 
Weighted-average common shares outstanding
39,059

 
37,499

Basic loss per share

($0.17
)
 

($0.32
)
Diluted loss per share:
 
 
 
Numerator: Net loss

($6,586
)
 

($12,116
)
Denominator:
 
 
 
Weighted-average common shares outstanding
39,059

 
37,499

Dilutive effect of stock awards

 

Total shares
39,059

 
37,499

Diluted loss per share

($0.17
)
 

($0.32
)

Stock awards to purchase approximately 4,641,000 and 4,531,000 shares for the three months ended June 30, 2015 and 2014, respectively, were excluded from the diluted EPS calculation because they were anti-dilutive.

4.    COMMITMENTS AND CONTINGENCIES
Contractual Obligations

The Company conducts its business in various leased facilities which, based on the lease terms, are considered to be operating leases.  There have been no material changes in our commitments under the lease agreements or other contractual obligations, as disclosed in our Annual Report on Form 10-K for the year ended March 31, 2015.

Legal Matters

The Company is subject to legal proceedings, claims, investigations and proceedings in the ordinary course of business. In accordance with U.S. GAAP, the Company makes a provision for a liability when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case.

Beginning on May 30, 2014, two putative class actions were filed in the U.S. District Court for the Southern District of New York against the Company, directors and certain officers at the time of the Company's initial public offering ("IPO") alleging violation of securities laws in connection with the Company's IPO and seeking unspecified damages. On August 15, 2014, the cases were consolidated with Charles Rankin appointed lead plaintiff. On October 14, 2014, the lead plaintiff filed a consolidated class action complaint (the “Complaint”) alleging violations of Regulation S-K and Sections 11 and 15 of the Securities Act. The Complaint alleges, among other things that the IPO’s registration statement contained (1) untrue statements and omissions of material facts related to the Company’s projected revenues for fiscal 2014, (2) materially inaccurate statements regarding the Company’s revenue recognition policy, and (3) omissions of known trends, uncertainties and significant risk factors as required to be disclosed by Regulation S-K. The Company has filed a motion to dismiss the Complaint. On July 1, 2015 the Court denied our motion to dismiss. We believe the Complaint is without merit, and we intend to vigorously defend it. The Company currently has no other outstanding litigation.

5.    BENEFIT PLANS

Covisint 401(k) Plan

Effective April 8, 2014, the Company effectively transitioned all Covisint employees from the Compuware 401(k) program to a newly established Covisint 401(k) program. All balances were transferred to the new plan. Under the new plan, the Company matches 33 percent of employees’ 401(k) contributions up to 2 percent of eligible earnings. Matching contributions vest 100

8


percent when an employee reaches one year of service. For the three months ended June 30, 2015 and 2014, the Company expensed $0.1 million and $0.2 million related to this program.

Covisint Stock-Based Compensation Plan

In August 2009, Covisint established a 2009 Long-Term Incentive Plan (“2009 Covisint LTIP”) allowing the Board of Directors of Covisint to grant stock options, stock appreciation rights, restricted stock, restricted stock units ("RSUs"), performance-based cash or RSU awards and annual cash incentive awards to employees and directors of Covisint and its affiliates. The 2009 Covisint LTIP reserves 7.5 million common shares of Covisint for issuance under this plan.

As of June 30, 2015, there were 4.2 million stock options and 0.3 million RSUs outstanding from the 2009 Covisint LTIP. No options issued subsequent to the IPO contain performance conditions. For the three months ended June 30, 2015 and 2014, 0.1 million options and 0.1 million options, respectively, were exercised by participants of the 2009 Covisint LTIP.

Stock Option Activity

A summary of option activity under the Company’s stock-based compensation plans as of June 30, 2015, and changes during the three months then ended is presented below (shares and intrinsic value in thousands):
 
 
Three Months Ended June 30, 2015
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term in Years
 
Aggregate
Intrinsic
Value
Options outstanding as of April 1, 2015
4,306

 

$3.93

 
 
 
 
Granted
205

 
2.19

 
 
 
 
Exercised
(136
)
 
1.81

 
 
 
 
Forfeited/Cancelled
(136
)
 
9.27

 
 
 
 
Options outstanding as of June 30, 2015
4,239

 

$3.74

 
5.71
 

$2,996

Options vested and expected to vest, net of estimated forfeitures, as of June 30, 2015
4,071

 

$3.74

 
5.56
 

$2,918

Options exercisable as of June 30, 2015
1,591

 

$3.54

 
2.79
 

$1,550


All options were originally granted at estimated fair market value for those granted prior to IPO, and at fair market value for those granted post IPO. Options expire ten years from the date of grant unless expiration has been otherwise accelerated in accordance with a termination and/or separation agreement.

Restricted Stock Unit Activity

A summary of non-vested RSUs activity as of June 30, 2015, and changes during the three months then ended is presented below. Shares and intrinsic value are presented in thousands.
 
 
Three Months Ended June 30, 2015
 
Shares    
 
Weighted
Average
Grant-Date
Fair Value
 
Aggregate
Intrinsic
Value
Non-vested RSU outstanding at April 1, 2015
338

 
 
 
 
Granted

 

 
 
Released

 
 
 
 
Forfeited

 
 
 
 
Dividend equivalents, net


 
 
 
 
Non-vested RSU outstanding at June 30, 2015
338

 
 
 
$
1,105



9


Stock Awards Compensation

For the three months ended June 30, 2015 and 2014, net stock awards compensation expense was recorded as follows in thousands:
 
Three Months Ended June 30,
 
2015
 
2014
Stock awards compensation classified as:
 
 
 
Cost of revenue

$30

 

$515

Research and development
26

 
66

Sales and marketing
109

 
605

General and administrative
984

 
1,432

Total stock awards compensation expense before income taxes

$1,149

 

$2,618


For the three months ended June 30, 2015, total stock compensation expense is comprised of $0.7 million according to the normal expense recognition of the grant, and $0.4 million of accelerated expense recognized due to the cancellation of options for certain current employees. For the three months ended June 30, 2014, stock compensation expense was comprised of $1.5 million according to the normal expense recognition schedule of the grant and $1.1 million of expense recognized due to employee terminations, which, pursuant to the terms of these options, accelerated vesting.

As of June 30, 2015, total unrecognized compensation cost of $4.0 million, net of estimated forfeitures, related to nonvested equity awards granted is expected to be recognized over a weighted-average period of approximately 2.3 years. The following table summarizes the Company’s estimated future recognition of its unrecognized compensation cost related to stock awards as of June 30, 2015 (in thousands).
 
Year Ending March 31,
Covisint Stock-Based Compensation Plan:
Total
 
2016
 
2017
 
2018
 
2019
 
2020
Stock Compensation Expense

$4,037

 

$1,665

 

$1,423

 

$735

 

$209

 
$
5




10


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

In this Quarterly Report, the terms “Covisint”, “the Company”, “we”, “us”, or “our”, mean Covisint Corporation and its subsidiaries on a consolidated basis unless otherwise expressly stated or the context otherwise requires.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes that appear in Part I, Item 1 in this Quarterly Report and with Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended March 31, 2015. In addition to historical information, the information we provide or statements made by our employees contains forward-looking statements that reflect our plans, estimates, assumptions and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and Item 1A of this Quarterly Report under "Risk Factors". Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies and operations, financing plans, potential growth opportunities, potential market opportunities and the effects of competition. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “seeks,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions and the negatives of those terms. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s plans, estimates, assumptions and beliefs only as of the date of this report. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


OVERVIEW
Covisint provides an open, developer friendly, enterprise class cloud platform (“Platform”) enabling organizations to build solutions that quickly and securely identify, authenticate and connect users, devices, applications and information. Our Platform has been successfully operating globally on an enterprise scale for over 12 years, and is the technology behind innovative industry solutions such as Hyundai's Blue LinkTM and Cisco's Services Exchange PlatformTM.

Our Platform provides a robust, and highly-secure cloud-based business-to-business ("B2B") exchange for automotive supply chains, providing the right information and access to the right person at the right time. This resulted in the development of unique and tightly-integrated technologies for identity management, messaging and portal services, which we offer as a Platform-as-a-Service ("PaaS"). We believe that we are well positioned in the PaaS marketplace to deliver on Internet of Things ("IoT") and identity-centric solutions.

Covisint recently executed a number of transformational strategic initiatives to enhance our long-term outlook. First, we applied our research and development investment toward to enabling our enterprise-grade, cloud-based PaaS to be easily deployed, in any data center globally, with a robust third-party developer environment for partners and third-parties to easily build on and extend the Platform. Next, we significantly reduced our services business by developing relationships with service partners who are qualified to set up, develop and implement solutions based upon the Platform’s technology. As a result of the shift away from providing services, Covisint’s services revenue declined to $2.8 million or 15% of revenue in the three months ended June 30, 2015 from $6.1 million or 28% of revenue for the three months ended June 30, 2014. Further, we reevaluated our underperforming healthcare portfolio and decided to stop selling our DocSite application to new customers and not to renew existing customers. As a result of these strategic decisions, revenue from the Company’s healthcare business gradually decreased during fiscal 2015, and we expect our healthcare revenue to account for less than 20% of the Company’s revenue in fiscal 2016.

We have significantly advanced our strategic partnership with Cisco Systems, Inc. ("Cisco"). Following entry into our Software License and Hosting Agreement with Cisco in November 2013, we have worked with Cisco to integrate our Platform with Cisco applications to build the Cisco Service Exchange Platform (“SXP”). In January and April 2015, we enabled Cisco to enter into the prime contracts with various divisions of General Motors Company (collectively, "General Motors" or "GM") to provide most of the service that we historically provided to GM. Under both of these contracts, Cisco paid us the annual service fees in advance. With Cisco’s involvement, we were able to extend the terms of each contract through April 2020 and eliminate GM’s ability to terminate these agreements for convenience. We retain our deep relationships with GM, and we are actively working to sell additional business to GM.


11


The majority of our revenue is generated through subscription fees that enable our customers to access our Platform. Subscription and support revenue accounted for $15.7 million and $15.5 million, or 85% and 72% of our total revenue for the three months ended June 30, 2015 and 2014.

We also generate revenue from the provision of services related to implementation, solution deployment and on-boarding of new customers onto our Platform. Services revenue accounted for $2.8 million and $6.1 million, or 15% and 28% of our total revenue for the three months ended June 30, 2015 and 2014.

As noted during fiscal year 2015 and the first quarter of fiscal year 2016, two of our contracts with General Motors were renewed with Cisco as the prime contractor and Covisint as the subcontractor. In the first quarter of fiscal year 2016, Cisco accounted for 31% of our total revenue, of which 21% is related to the transfer of these General Motors contracts and the augmentation of the SXP platform. Our stand alone business with General Motors accounted for 14% of our total revenue in the three months ended June 30, 2015. Collectively the General Motors standalone revenue and the related Cisco revenue was 35% of total revenue for the three months ended June 30, 2015, as compared to 29% of total revenue for the three months ended June 30, 2014 when Covisint was directly contracting with General Motors.

Our contracts related to the automotive industry accounted for 51% and 45% of our total revenue for the three months ended June 30, 2015 and 2014. The healthcare industry accounted for 20% and 32% of our total revenue in the three months ended June 30, 2015 and 2014. Our remaining revenue resides in the enterprise business unit that services Cisco, the energy, financial services, travel and other non-automotive and non-healthcare industries. Revenue from outside of the U.S. accounted for 14% and 18% of our total revenue in the three months ended June 30, 2015 and 2014.

To support our growth strategies and capitalize on current technology trends, we are actively investing in our business and do not expect to be profitable during fiscal 2016. We experienced net (losses) of $(6.6) million and $(12.1) million in the three months ended June 30, 2015 and 2014. Our improvement in net (losses) of $5.5 million was due to the restructuring of our services business which included our shift away from developing and selling applications that require significant amounts of services to implement, as well as to a reduction of stock compensation expense of $1.5 million. In addition, we made, and continue to make, substantial investments to build our solutions and services, grow and maintain our business and acquire customers.
KEY METRICS

In addition to reporting financial results in accordance with generally accepted accounting principles in the United States, or GAAP, we monitor a number of other metrics to evaluate our business, measure our performance, identify trends affecting our business, allocate capital and make strategic decisions.

Adjusted Gross Profit and Adjusted Gross Margin

Adjusted gross profit represents gross profit, adjusted for amortization of capitalized software costs associated with our research and development activities which are currently classified within cost of revenue, as well as for stock based compensation associated with certain of our professional services and operations employees. Adjusted gross margin represents adjusted gross profit as a percentage of total revenue.

We have historically capitalized a significant portion of our research and development costs. Our total research and development costs incurred were $4.0 million and $3.9 million during the three months ended June 30, 2015 and 2014. Of our total research and development costs incurred, we capitalized 10% and 20% during the three months ended June 30, 2015 and 2014. The decreased capitalization of our research and development costs for the three months ended June 30, 2015, compared to the same period in 2014, was due to relatively more research and development projects being in the planning stages in the current quarter, while the prior period consisted of more projects in the development stages.

We believe that adjusted gross margin, when viewed with our results under U.S. GAAP and the accompanying reconciliation, provides additional information that is useful for evaluating our operating performance. Additionally, we believe that adjusted gross margin provides a more meaningful comparison of our operating results against those of other companies in our industry. We believe that including these costs in our results of operations results in a lack of comparability between our operating results and those of our peers in the industry, the majority of which do not have comparable amortization costs related to capitalized software. However, adjusted gross margin is not a measure of financial performance under U.S. GAAP and, accordingly, should not be considered as an alternative to gross margin as an indicator of operating performance.

The table below provides reconciliations between the non-U.S. GAAP financial measures discussed above to the comparable U.S. GAAP measures of gross profit:
 
Three Months Ended June 30,
 
2015
 
2014
Gross profit
$8,705
 
$6,321
Gross margin
47
%
 
29
%
Adjustments:
 
 
 
Stock compensation expense—cost of revenue
$30
 
$515
% of total revenue
%
 
2
%
Amortization of capitalized software—cost of revenue
$904
 
$1,643
% of total revenue
5
%
 
8
%
Non-GAAP gross profit
$9,639
 
$8,479
Non-GAAP gross margin
52
%
 
39
%
COMPONENTS OF OUR RESULTS OF OPERATIONS

Revenue

Our revenue is primarily comprised of fees related to subscription and support as well as services performed. Subscription and support revenue includes fees for our customers and their users to access our Platform. Service revenue is generated from implementation, solution deployment and on-boarding. Implementation services typically consist of user migration, content migration, branding and configuration to support customer-specific work flows. Our services engagements typically occur in phases and can vary from a few weeks to several months depending on the scope and complexity of the solution. Our customers

12


may choose to do much of this work in-house, through a third party, or with Covisint. We currently subcontract portions of our service engagements to third-party service partners to supplement our staffing needs within this area of the business.

Services contract value varies significantly for each customer agreement, and can be impacted by a number of trends which make the prediction of our future services revenue difficult. These trends include, but are not necessarily limited to, improvements in our Platform that make it easier for our customers to build and launch new business process innovations on the Platform, and a reduction in the effort required to launch the customer.

Our revenue generally fluctuates, and we expect it to continue to fluctuate, between periods due to inconsistent timing of sales, revenue recognition requirements (e.g., acceptance), changes in customer requirements and other factors. As a result, transactions that were expected to be recognized in one period may be recognized in a different period, which may materially affect our financial performance in a reporting period.

Cost of Revenue

Our cost of revenue is primarily comprised of salaries and personnel-related expenses related to our customer support, implementation, solution deployment, on-boarding and data center operations, the cost of professional services provided by third-party contractors, depreciation, amortization and impairment expenses related to capitalized research and development, acquisitions and capital expenditures, third-party hosting fees, third-party software license fees, and outside services related to our call center. Where we have established third-party evidence of the stand-alone value of our services, we recognize expense with the associated revenue recognition as services are delivered. Costs associated with deferred services revenue are recognized ratably, generally over five years, beginning upon customer acceptance of the deliverable consistent with the associated revenue.

We expect our cost of revenue may fluctuate as a percentage of total revenue due to relative changes in our services revenue, changes in the percentage of services recognized using the proportional performance method, the amount and timing of depreciation and amortization, changes in the amount of services performed by our customers or other vendors and the mix of subscription and support revenue relative to services revenue.

Research and Development

Research and development costs are primarily comprised of salaries and personnel-related expenses, services provided by third-party contractors related to software development, software license and hardware fees and depreciation and amortization related to acquisitions and capital expenditures.
 
We focus our research and development on new and expanded features of our Platform and vertical-specific solutions, utilizing an agile delivery methodology for our Platform enhancements. Our capitalized research and development costs are amortized as a cost of revenue ratably over 60 months upon completion of the project. We expect research and development costs incurred to decrease in the future as a percentage of revenue.

Sales and Marketing

Sales and marketing costs are primarily comprised of salaries and personnel-related expenses, commissions, travel expense, marketing program fees, services provided by third-party contractors related to our marketing campaigns and amortization related to customer relationship agreements acquired as a result of various acquisitions. We plan to invest further in sales and marketing to create brand awareness, expand the scope and scale of our global operations, develop our sales channel and increase revenue from existing customers. We expect sales and marketing costs to increase in fiscal 2016 as a percentage of total revenue.

General and Administrative
    
Effective April 1, 2014, we completed our general and administrative separation from Compuware Corporation, our former parent, by assuming stand-alone finance, information technology, human resources, legal, and internal audit functions. General and administrative costs are primarily comprised of salaries and personnel-related expenses for these functions and stock and cash incentive compensation for certain corporate executive leadership roles, as well as facility and technology related costs associated with our corporate functions.

Income Taxes

Provision for income taxes is comprised of federal and state taxes in the United States as well as certain foreign tax jurisdictions. Income taxes are accounted for using the asset and liability approach. Deferred income taxes are provided for the differences

13


between the tax bases of assets or liabilities and their reported amounts in our financial statements and net operating loss and tax credit carryforwards.

The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. These deferred tax assets are subject to periodic assessments as to recoverability. If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recorded which would increase the provision for income taxes. In making such determinations, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Given the Company's historical loss position in the U.S., it has been determined the Company does not expect to realize the benefits of its deferred tax assets, resulting in a full valuation allowance preventing the recognition of any potential deferred tax asset for its U.S. operations.

CRITICAL ACCOUNTING POLICIES

There have been no significant changes to our Critical Accounting Policies as described in our Annual Report on Form 10-K for the year ended March 31, 2015.


STOCK-BASED COMPENSATION

Stock award compensation expense is recognized, net of an estimated forfeiture rate, on a straight-line basis over the requisite service period of the award.


RESULTS OF OPERATIONS

The following table is a summary of our condensed consolidated statements of comprehensive loss data (in thousands, except for per share data):
 

14


 
 
Three Months Ended June 30,
 
 
2015
 
2014
 
 
 
 
 
Condensed Consolidated Statements of Comprehensive Loss Data:
 
 
 
 
Subscription and support
 
$15,664
 
$15,509
Services
 
2,818

 
6,078

Total revenue
 
18,482

 
21,587

Cost of revenue(1)
 
9,777

 
15,266

Gross profit
 
8,705

 
6,321

Operating expenses:
 
 
 
 
Research and development(1)
 
3,663

 
3,116

Sales and marketing(1)
 
7,476

 
9,772

General and administrative(1)
 
4,087

 
5,546

Total operating expenses
 
15,226

 
18,434

Operating loss
 
(6,521
)
 
(12,113
)
Other income
 
2

 
22

Loss before income tax provision
 
(6,519
)
 
(12,091
)
Income tax provision
 
67

 
25

Net loss
 
($6,586)
 
($12,116)
Basic and diluted loss per share
 
($0.17)
 
($0.32)
Weighted-average shares outstanding, Basic and diluted
 
39,059

 
37,499


(1)
All future stock compensation is expected to be granted in the form of Covisint stock awards or restricted stock units and recorded as a non-cash expense. The statements and line items above include stock compensation as detailed in the table below.


 
 
 
Three Months Ended June 30,
 
 
2015
 
2014
Stock awards compensation classified as:
 
Cost of revenue
 
$
30

 
$
515

Research and development
 
26

 
66

Sales and marketing
 
109

 
605

General and administrative
 
984

 
1,432

Total stock awards compensation expense before income taxes
 
1,149

 
2,618

 
The following table sets forth a summary of our condensed consolidated statements of comprehensive loss as a percentage of our total revenue:


15


 
Three Months Ended June 30,
 
2015
 
2014
Condensed Consolidated Statements of Comprehensive Loss Data:
 
 
 
Subscription and support
85
 %
 
72
 %
Services
15

 
28

Total revenue
100

 
100

Cost of revenue(1)
53

 
71

Gross profit
47

 
29

Operating expenses:
 
 
 
Research and development(1)
20

 
14

Sales and marketing(1)
40

 
45

General and administrative(1)
22

 
26

Total operating expenses
82

 
85

OPERATING LOSS
(35
)
 
(56
)
Other income
0

 
0

Loss from operations before for income tax provision
(35
)
 
(56
)
Income tax provision
0

 
0

Net loss
(35
)%
 
(56
)%
________________________________________________ 
(1)
All future stock compensation is expected to be granted in the form of Covisint stock awards and recorded as a non-cash expense. Refer to the table above for the breakdown of stock compensation included in these line item percentages.
THREE MONTHS ENDED JUNE 30, 2015 AND 2014

Revenue

Revenue derived from our subscription and support and services is presented in the table below:
 
 
Three Months Ended June 30,
 
Period-to-Period
Change
 
2015
 
2014
 
$    
 
%    
 
(In thousands)
 
 
Subscription and support

$15,664

 

$15,509

 

$155

 
1
 %
Services
2,818

 
6,078

 
(3,260
)
 
(54
)%
Total revenue

$18,482

 

$21,587

 

($3,105
)
 
(14
)%

Our total revenue decreased to $18.5 million for the three months ended June 30, 2015 from $21.6 million in the three months ended June 30, 2014, representing a 14% decrease in total revenue.

Subscription and support revenue was $15.7 million for the three months ended June 30, 2015 as compared to $15.5 million for the three months ended June 30, 2014. The increase in subscription revenue was due to new business offset by the planned decline in our healthcare subscription revenue and shift out of lower margin healthcare application business. Adjusting for the planned decline in our healthcare application business, our subscription business has grown 12% period to period.
    
Our services revenue declined to $2.8 million for the three months ended June 30, 2015, as compared to $6.1 million for the three months ended June 30, 2014, respectively, representing a decline of 54%. For the three months ended June 30, 2015 the decline in services revenue are attributed to: 1) an improvement in the ease of implementation of our Platform that results in quicker, less costly installations; 2) improvements in our platform that allow customers to perform portions of the implementations themselves; 3) a reduction in ad hoc service projects with major subscription customers; and 4) shifting away from the development of applications that require significant amount of services to implement to our service partners.

Cost of Revenue


16


Cost of revenue is presented in the table below:

 
Three Months Ended June 30,
 
Period-to-Period
Change
 
2015
 
2014
 
$    
 
%    
 
(In thousands)
 
 
Cost of revenue

$9,777

 

$15,266

 

($5,489
)
 
(36
)%
Gross margin
47
%
 
29
%
 
 
 
 

Cost of revenue decreased $5.5 million for the three months ended June 30, 2015 as compared to the same period in 2014. The decrease is primarily attributable to a $4.6 million decline in personnel expense due to the restructuring of our services business, which included our shift away from developing and selling applications that require significant amounts of services to implement, as well as a reduction in stock compensation expense.

Our gross margin increased to 47% for the three months ended June 30, 2015, as compared with 29% for the same period in 2014. The improved margins were primarily due to the execution of cost savings initiatives related to the changes in our services business discussed above, as well as our planned shift out of lower margin subscription businesses.


Research and Development

Research and development costs incurred, expensed and capitalized are presented in the table below:
 
 
Three Months Ended June 30,
 
Period-to-Period
Change
 
 
2015
 
2014
 
$    
 
%    
 
 
(In thousands)
 
 
 
Research and development costs incurred

$4,063

 

$3,906

 

$157

 
4
 %
 
Capitalized internal software costs
(400
)
 
(790
)
 
390

 
(49
)%
 
Research and development costs expensed

$3,663

 

$3,116

 

$547

 
18
 %
 
Percentage of total revenue:
 
 
 
 
 
 
 
 
Research and development costs incurred
22
%
 
18
%
 
 
 
 
 
Research and development costs expensed
20
%
 
14
%
 
 
 
 
 

Research and development costs incurred increased for the three months ended June 30, 2015, as compared to the same period in 2014, primarily due to an increase in development costs to develop our Next-gen platform and our Covisint "Anywhere" offering.

We capitalized $0.4 million and $0.8 million of internal software (research and development) costs for the three months ended June 30, 2015 and 2014, respectively. The decreased capitalization of our research and development costs for the three months ended June 30, 2015, compared to the same period in 2014, was due to relatively more research and development projects being in the planning stages in the current quarter, while the prior period consisted of more projects in the development stages.

Sales and Marketing

Sales and marketing costs are presented in the table below:
 
 
Three Months Ended June 30,
 
Period-to-Period
Change
 
2015
 
2014
 
$    
 
%    
 
(In thousands)
 
 
Sales and marketing

$7,476

 

$9,772

 

($2,296
)
 
(23
)%
Percentage of total revenue
40
%
 
45
%
 
 
 
 


17


Sales and marketing costs decreased for the three months ended June 30, 2015, compared to the same period in 2014, primarily due to a $1.4 million decrease in salaries and personnel expense due to the restructuring of the direct sales and marketing organizations, reflective of our shift out of selling lower margin healthcare applications. The remaining decrease is primarily due to a decrease in stock compensation expense of $0.5 million.

General and Administrative

General and administrative costs are presented in the table below:
 
 
Three Months Ended June 30,
 
Period-to-Period
Change
 
2015
 
2014
 
$    
 
%    
 
(In thousands)
 
 
General and administrative

$4,087

 

$5,546

 

($1,459
)
 
(26
)%
Percentage of total revenue
22
%
 
26
%
 
 
 
 

General and administrative costs decreased by $1.5 million for the three months ended June 30, 2015, as compared to the same period in 2014 which was primarily a result of our continued rationalization of our general and administrative structure. Stock compensation expense also decreased $0.5 million.


LIQUIDITY AND CAPITAL RESCOURCES
In summary, our cash flows for the three months ended June 30, 2015 and 2014 were:
 
Three Months Ended June 30,
 
2015
 
2014
Condensed and Consolidated Statement of Cash Flows Data:
(In thousands)
Net cash provided by (used in) operating activities

$95

 

($7,977
)
Net cash used in investing activities
(3,275
)
 
(1,610
)
Net cash provided by financing activities
247

 
3,184

Effect of exchange rate
43

 
(4
)
Net change in cash

($2,890
)
 

($6,407
)

The consolidated statements of cash flows included in this report compute net cash from operating activities using the indirect cash flow method. Therefore, non-cash adjustments and net changes in assets and liabilities (net of effects from acquisitions and currency fluctuations) are adjusted from net income to derive net cash from operating activities.

Cash Flows from Operating Activities
    
Cash provided by (used in) operating activities was $8.1 million favorable for the three months ended June 30, 2015, compared to the same period in 2014, due to our improved cost structure and favorable working capital fluctuations.

Cash Flows from Investing Activities

Cash used in investing activities typically consists of the purchase of property and equipment associated with our infrastructure and the expenditures on capitalized internal software (research and development) costs related to expanding our cloud-based Platform. In the three months ended June 30, 2015 purchases of property and equipment primarily consisted of lease hold improvements associated with the relocation of our corporate headquarters to Southfield, Michigan in May 2015.

Cash used in investing activities increased $1.7 million for the three months ended June 30, 2015, compared with the same period in 2014, primarily due to a $2.1 million increase in cash paid for capital expenditures and leasehold improvements, partially offset by a $0.4 decrease for capitalized research and development.

18



Cash Flows from Financing Activities

Cash provided by financing activities decreased $2.9 million for the three months ended June 30, 2015, as compared with the same period in 2014, primarily due to approximately $3.0 million of net payments from our former parent company in the prior period. This was partially offset by $0.1 million increase in proceeds received from the exercises of stock awards.
RECENTLY ISSUED ACCOUNTING PRONOUCEMENTS

New accounting guidance that we have recently adopted, as well as accounting guidance that has been recently issued, but not yet adopted by us, is included in Note 1 of the notes to the condensed consolidated financial statements appearing in Part I, Item 1 of this Quarterly Report.
CONTRACTUAL OBLIGATIONS

Contractual obligations represent future cash commitments and liabilities under agreements with third parties. There have been no material changes in our commitments under contractual obligations, as disclosed in our Annual Report on Form 10-K for the year ended March 31, 2015.

OFF-BALANCE SHEET ARRANGEMENTS

We currently do not have any off-balance sheet or non-consolidated special purpose entity arrangements as defined by the applicable rules and regulations promulgated by the Securities and Exchange Commission (“SEC”).


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed primarily to market risks associated with foreign currency exchange rates. We do not use derivative financial instruments or forward foreign exchange contracts for investment, speculative or trading purposes. We believe our foreign currency risk is minimal as 86% and 82% of our revenue was based in U.S. dollars for the three months ended June 30, 2015 and 2014, respectively. In addition, we have no long-term assets or liabilities in foreign currencies. We do not have a material exposure to market risk with respect to investments.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures



Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act), as of the end of the period covered by this Quarterly Report. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

19


In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving their objectives. Based upon the evaluation of our disclosure controls and procedures as of June 30, 2015, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.


Changes in Internal Control over Financial Reporting

There has been no change in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended June 30, 2015 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.


20


PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS



Beginning on May 30, 2014, two putative class actions were filed in the U.S. District Court for the Southern District of New York against the Company, directors and certain officers at the time of the Company's initial public offering ("IPO") alleging violation of securities laws in connection with the Company's IPO and seeking unspecified damages. On August 15, 2014, the cases were consolidated with Charles Rankin appointed lead plaintiff. On October 14, 2014, the lead plaintiff filed a consolidated class action complaint (the “Complaint”) alleging violations of Regulation S-K and Sections 11 and 15 of the Securities Act. The Complaint alleges, among other things that the IPO’s registration statement contained (1) untrue statements and omissions of material facts related to the Company’s projected revenues for fiscal 2014, (2) materially inaccurate statements regarding the Company’s revenue recognition policy, and (3) omissions of known trends, uncertainties and significant risk factors as required to be disclosed by Regulation S-K. The Company has filed a motion to dismiss the Complaint. On July 1, 2015, the Court denied our motion to dismiss. We believe the Complaint is without merit, and we intend to vigorously defend it. The results of legal proceedings cannot be predicted with certainty. Should we fail to prevail in any of these legal matters, our financial condition and results of operations could be materially adversely affected.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report, you should carefully consider the risks under the heading "Risk Factors" in Part I, Item 1A in our Annual Report on Form 10-K filed with the SEC on May 26, 2015, which risks could materially affect our business, financial condition or future results. There have been no material changes in our risk factors from those described in the Annual Report. These risks are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or results of operations.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Not Applicable.

21


ITEM 3. DEFAULT UPON SENIOR SECURITIES
Not Applicable.
ITEM 4. MINE SAFETY DISCLOSURES
Not Applicable.
ITEM 5. OTHER INFORMATION
Not Applicable.
ITEM 6. EXHIBITS

The following exhibits are filed herewith.
Exhibit Number
 
Description of Document
10.1
 
Form Severance Agreement
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act
32.1
 
Certification pursuant to 18 U.S.C. Section 1350 and Rule 13a-14(b) of the Securities Exchange Act
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document


22


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
COVISINT CORPORATION
 
 
 
Date:
August 7, 2015
By: /s/ Samuel M. Inman, III
 
 
Samuel M. Inman, III
 
 
Chief Executive Officer
 
 
Principal Executive Officer
 
 
 
Date:
August 7, 2015
By: /s/ Enrico Digirolamo
 
 
Enrico Digirolamo
 
 
Chief Financial Officer
 
 
Principal Accounting Officer
 
 
 



23